Product Name: Lenvatinib mesylate CAS NO:857890-39-2
Chemical & Physical Properties:
Appearance: white powder
Lovatinib mesylate is the mesylate of levatinib. Lovatinib is a multi-target tyrosine kinase inhibitor developed by Eisai Japan. It has a novel binding mode. In addition to inhibiting other pro-angiogenic and oncogenic signaling pathways related tyrosine kinases involved in tumor proliferation, it can also selectively inhibit the kinase activity of vascular endothelial growth factor (VEGF) receptors, such as VEGF-1, VEGF-2 and VEGF- 3 etc.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.